Cargando…

Improved outcomes and staging in non-small-cell lung cancer guided by a molecular assay

There remains a critical need for improved staging of non-small-cell lung cancer, as recurrence and mortality due to undetectable metastases at the time of surgery remain high even after complete resection of tumors currently categorized as ‘early stage.’ A 14-gene quantitative PCR-based expression...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gupta, Alexander R, Woodard, Gavitt A, Jablons, David M, Mann, Michael J, Kratz, Johannes R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Medicine Ltd 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9039775/ https://www.ncbi.nlm.nih.gov/pubmed/34435876 http://dx.doi.org/10.2217/fon-2021-0517

Ejemplares similares

Comparison of Conventional TNM and Novel TNMB Staging Systems for Non–Small Cell Lung Cancer
por: Haro, Greg J., et al.
Publicado: (2019)

Surgery for pleural mesothelioma, when it is indicated and why: arguments against surgery for malignant pleural mesothelioma
por: Woodard, Gavitt A., et al.
Publicado: (2020)

2460: Change in duration of postoperative antibiotic prophylaxis in esophagectomy patients: Outcomes in a single academic institution
por: Wang, Sue, et al.
Publicado: (2018)

FAIM2, as a novel diagnostic maker and a potential therapeutic target for small-cell lung cancer and atypical carcinoid
por: Kang, Hio Chung, et al.
Publicado: (2016)

Genetic and immunologic features of recurrent stage I lung adenocarcinoma
por: Kratz, Johannes R., et al.
Publicado: (2021)

The role of stem cells in airway repair: implications for the origins of lung cancer
por: Mulvihill, Michael S., et al.
Publicado: (2013)

Bioinformatic Approaches to Validation and Functional Analysis of 3D Lung Cancer Models
por: Li, P. Jonathan, et al.
Publicado: (2021)

Case report: recurrent metastatic breast cancer in internal mammary dissection bed discovered at the time of coronary bypass
por: Woodard, Gavitt A., et al.
Publicado: (2019)

A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation—part 1: a guide to decision-making
por: Detterbeck, Frank C., et al.
Publicado: (2022)

287 Genomic and Immunologic Characterization of Lung Adenocarcinoma in Never Smokers vs. Smokers
por: Li, P. Jonathan, et al.
Publicado: (2023)

Central Airway Obstruction Due to Tracheal Glomus Tumor
por: Haro, Greg J., et al.
Publicado: (2018)

Gli promotes epithelial-mesenchymal transition in human lung adenocarcinomas
por: Li, Hui, et al.
Publicado: (2016)

Significance of different response evaluation criteria in predicting progression‐free survival of lung cancer with certain imaging characteristics
por: Yang, Dengxia, et al.
Publicado: (2016)

Connection through cardiothoracic surgery subspecialty collaboration: Strategies for Early Faculty Peer Network Development
por: Lee, Madonna E., et al.
Publicado: (2022)

The impact of adjuvant EGFR-TKIs and 14-gene molecular assay on stage I non–small cell lung cancer with sensitive EGFR mutations
por: Jiang, Yu, et al.
Publicado: (2023)

A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation—part 4: systematic review of evidence involving SBRT and ablation
por: Park, Henry S., et al.
Publicado: (2022)

Outcomes of Image-Guided Moderately Hypofractionated Radiotherapy for Stage III Non-Small-Cell Lung Cancer
por: Zhang, Yang, et al.
Publicado: (2021)

Feasibility of Tomotherapy-Based Image-Guided Radiotherapy for Small Cell Lung Cancer
por: Nguyen, Nam P., et al.
Publicado: (2013)

A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation—part 2: systematic review of evidence regarding resection extent in generally healthy patients
por: Detterbeck, Frank C., et al.
Publicado: (2022)

A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation—part 3: systematic review of evidence regarding surgery in compromised patients or specific tumors
por: Bade, Brett C., et al.
Publicado: (2022)

EMX2 Is a Predictive Marker for Adjuvant Chemotherapy in Lung Squamous Cell Carcinomas
por: Yue, Dongsheng, et al.
Publicado: (2015)

Whole exome and targeted deep sequencing identify genome-wide allelic loss and frequent SETDB1 mutations in malignant pleural mesotheliomas
por: Kang, Hio Chung, et al.
Publicado: (2016)

Differential gene expression identifies KRT7 and MUC1 as potential metastasis-specific targets in sarcoma
por: Jiang, Long, et al.
Publicado: (2019)

Clinical outcomes of image-guided proton therapy for histologically confirmed stage I non-small cell lung cancer
por: Nakajima, Koichiro, et al.
Publicado: (2018)

Can LMWH improve the outcome of patients with inoperable stage III non-small cell lung cancer?
por: Kucukoner, Mehmet, et al.
Publicado: (2012)

The Crosstalk between Src and Hippo/YAP Signaling Pathways in Non-Small Cell Lung Cancer (NSCLC)
por: Hsu, Ping-Chih, et al.
Publicado: (2020)

Outcomes of patients with unresected stage III and stage IV non-small cell lung cancer: A single institution experience
por: Tiwana, Manpreet Singh, et al.
Publicado: (2013)

Clinical Guideline-Guided Outcome Consistency for Surgically Resected Stage III Non-Small Cell Lung Cancer: A Retrospective Study
por: Kuroda, Hiroaki, et al.
Publicado: (2021)

Survival Outcomes with Photodynamic Therapy, Chemotherapy and Radiation in Patients with Stage III or Stage IV Non-Small Cell Lung Cancer
por: Chhatre, Sumedha, et al.
Publicado: (2021)

Frizzled-8 receptor is activated by the Wnt-2 ligand in non-small cell lung cancer
por: Bravo, Dawn T, et al.
Publicado: (2013)

Treatment Outcomes in Elderly with Advanced-Stage Non-small Cell Lung Cancer
por: Tam, Terence Chi-Chun, et al.
Publicado: (2013)

Outcomes with durvalumab after chemoradiotherapy in stage IIIA-N2 non-small-cell lung cancer: an exploratory analysis from the PACIFIC trial
por: Senan, S., et al.
Publicado: (2022)

Distant Metastasis and Survival Outcomes after Computed Tomography-Guided Needle Biopsy in Resected Stage I-III Non-Small Cell Lung Cancer
por: Xi, Yuhui, et al.
Publicado: (2017)

Comparison of outcomes in patients with stage III versus limited stage IV non-small cell lung cancer
por: Cheruvu, Praveena, et al.
Publicado: (2011)

Detection of E2A-PBX1 fusion transcripts in human non-small-cell lung cancer
por: Mo, Min-Li, et al.
Publicado: (2013)

Chemotherapy of non-small cell lung carcinoma guided by an in vitro drug resistance assay measuring total tumour cell kill.
por: Wilbur, D. W., et al.
Publicado: (1992)

Targeted Molecular Treatments in Non-Small Cell Lung Cancer: A Clinical Guide for Oncologists
por: Bui, Kim Tam, et al.
Publicado: (2018)

Improved internal control for molecular diagnosis assays
por: Vinayagamoorthy, T., et al.
Publicado: (2015)

Image-Guided Hypofractionated Proton Therapy in Early-Stage Non–Small Cell Lung Cancer: A Phase 2 Study
por: Kharod, Shivam M., et al.
Publicado: (2020)

Hippocampal Metastasis Rate Based on Non-Small Lung Cancer TNM Stage and Molecular Markers
por: Ahn, Sung Jun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a1090nta4jj1u76j3488n7t8sl